D

Deep Genomics pricing

No pricing page, rate card, unit of charge or commercial disclosure of any kind exists. Deep Genomics names no customer or partner at all, so there is not even a deal announcement to infer structure from. The site states that the platform advances discovery problems internally and in support of major pharmaceutical partners without naming one, and the news archive carries no collaboration, license, upfront, milestone or royalty arrangement.

Pricing terms

How Deep Genomics pricing works

Pricing model
Not established. The company describes model driven discovery work carried out internally and in support of pharmaceutical partners, but discloses no partner, agreement or commercial structure, so the basis on which it charges cannot be determined from public sources. No software license, subscription or platform access is offered for sale.
Implementation
Not published, and nothing public establishes whether an implementation exists to charge for. The company operates two laboratory facilities totaling more than 10,000 square feet and generates purpose built datasets for training and validation, so substantial cost sits on its own side of any engagement, but with no disclosed partner arrangement there is no way to establish how that cost is recovered or whether partners fund it directly.

No funding round or investor is disclosed on the site either. The September 2023 plan to become a forward integrated biopharmaceutical company, which would have implied a different commercial model entirely, is no longer reflected anywhere and no announcement of the change appears. Public sources do not show whether this company sells access, sells programs, or is funded principally by equity.

Compared on price

Deep Genomics pricing against its alternatives

Published prices for Deep Genomics and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All Deep Genomics alternatives →

Questions

Deep Genomics pricing, answered

How much does Deep Genomics cost?

Deep Genomics does not publish a price. Deep Genomics names no customer or partner at all, so there is not even a deal announcement to infer structure from. The site states that the platform advances discovery problems internally and in support of major pharmaceutical partners without naming one, and the news archive carries no collaboration, license, upfront, milestone or royalty arrangement.

Does Deep Genomics charge an implementation fee?

Not published, and nothing public establishes whether an implementation exists to charge for. The company operates two laboratory facilities totaling more than 10,000 square feet and generates purpose built datasets for training and validation, so substantial cost sits on its own side of any engagement, but with no disclosed partner arrangement there is no way to establish how that cost is recovered or whether partners fund it directly.